As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2025 in the “Cancer Biomarkers” Section, which are listed below:

1. “Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological Malignancies”
by Gokce A. Toruner, Shimin Hu, Sanam Loghavi, Chi Young OK, Zhenya Tang, Qing Wei, Rashmi Kanagal-Shamanna, L. Jeffrey Medeiros and Guilin Tang
Cancers 2025, 17(9), 1436; https://doi.org/10.3390/cancers17091436
Available online: https://www.mdpi.com/2072-6694/17/9/1436

2. “A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals”
by Norma A. Palma, Aimee L. Lucas, Bryson W. Katona, Alcibiade Athanasiou, Natasha M. Kureshi, Lisa Ford, Thomas Keller, Stephen Weber, Ralph Schiess, Thomas King et al.
Cancers 2025, 17(11), 1866; https://doi.org/10.3390/cancers17111866
Available online: https://www.mdpi.com/2072-6694/17/11/1866

3. “Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment”
by Stefania Drymiotou, Efthymia Theodorou, Kathrine Sofia Rallis, Marios Nicolaides and Michail Sideris
Cancers 2025, 17(3), 545; https://doi.org/10.3390/cancers17030545
Available online: https://www.mdpi.com/2072-6694/17/3/545

4. “Development of a miRNA-Based Model for Lung Cancer Detection”
by Kai Chin Poh, Toh Ming Ren, Goh Liuh Ling, John S Y Goh, Sarrah Rose, Alexa Wong, Sanhita S. Mehta, Amelia Goh, Pei-Yu Chong, Sim Wey Cheng et al.
Cancers 2025, 17(6), 942; https://doi.org/10.3390/cancers17060942
Available online: https://www.mdpi.com/2072-6694/17/6/942

5. “Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent Advances”
by Sahana Aiyer, Tae-Hee Kim, Katharine Collier, Raphael Pollock, Claire Verschraegen, Daniel G. Stover and Gabriel Tinoco
Cancers 2025, 17(6), 1040; https://doi.org/10.3390/cancers17061040
Available online: https://www.mdpi.com/2072-6694/17/6/1040

6. “Proportional Correlation Between Systemic Inflammation Response Index and Gastric Cancer Recurrence Time: A Retrospective Study”
by Kyungryun In, Sunhyung Kang, Hyunseok Lee, Hyuksoo Eun, Heeseok Moon, Eaumseok Lee, Seokhyun Kim, Jaekyu Sung and Byungseok Lee
Cancers 2025, 17(9), 1415; https://doi.org/10.3390/cancers17091415
Available online: https://www.mdpi.com/2072-6694/17/9/1415

7. “Personalized Treatment in Ovarian Cancer: A Review of Disease Monitoring, Biomarker Expression, and Targeted Treatments for Advanced, Recurrent Ovarian Cancers”
by Victoria M. Ettorre, Abdelrahman AlAshqar, Namrata Sethi and Alessandro D. Santin
Cancers 2025, 17(11), 1822; https://doi.org/10.3390/cancers17111822
Available online: https://www.mdpi.com/2072-6694/17/11/1822

8. “Synergistic Inhibition of Drug Resistant KRAS Mutant Non-Small Cell Lung Cancer by Co-Targeting AXL and SRC”
by Soumavo Mukherjee, Dhananjay Suresh, Ajit Zambre, Sairam Yadavilli, Shreya Ghoshdastidar, Anandhi Upendran and Raghuraman Kannan
Cancers 2025, 17(3), 490; https://doi.org/10.3390/cancers17030490
Available online: https://www.mdpi.com/2072-6694/17/3/490

9. “Untargeted Metabolomics and Liquid Biopsy Investigation of Circulating Biomarkers in Soft Tissue Sarcoma”
by Daniela Grasso, Barbara Marzocchi, Guido Scoccianti, Ilaria Palchetti, Domenico Andrea Campanacci, Lorenzo Antonuzzo, Federico Scolari, Serena Pillozzi and Andrea Bernini
Cancers 2025, 17(3), 553; https://doi.org/10.3390/cancers17030553
Available online: https://www.mdpi.com/2072-6694/17/3/553

10. “Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions”
by Hiroshi Kobayashi, Hiroshi Shigetomi and Shogo Imanaka
Cancers 2025, 17(9), 1447; https://doi.org/10.3390/cancers17091447
Available online: https://www.mdpi.com/2072-6694/17/9/1447

11. “Mapping the Binding Sites of CA125-Specific Antibodies on a Revised Molecular Model of MUC16”
by Chien-Wei Wang, Anubhuti Srivastava, Eliza K. Hanson, Caitlin R. McEntee, Trisha Nair, Jane C. March and Rebecca J. Whelan
Cancers 2025, 17(9), 1458; https://doi.org/10.3390/cancers17091458
Available online: https://www.mdpi.com/2072-6694/17/9/1458

12. “Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial”
by Sara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino, Alejandro Martín Garcia-Sáncho, Fernando Carnicero-González, Natalia Palazón-Carrión, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Antonio Rueda-Domínguez, Natividad Martínez-Banaclocha et al.
Cancers 2025, 17(3), 532; https://doi.org/10.3390/cancers17030532
Available online: https://www.mdpi.com/2072-6694/17/3/532

13. “Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer”
by Tsen-Long Yang, Chung-Hsin Tsai, Ying-Wen Su, Yuan-Ching Chang, Fang Lee, To-Yu Huang, Fang-Yi Li and Po-Sheng Yang
Cancers 2025, 17(4), 671; https://doi.org/10.3390/cancers17040671
Available online: https://www.mdpi.com/2072-6694/17/4/671

14. “Detection of Genomic Copy Number Variations in Ovarian Cancer in the Peripheral Blood System”
by Lena Wahl, Ulyana Hliabtsova, Xueqian Qian, Anastasia Klopf, Nina Hedemann, Inken Flörkemeier, Christoph Rogmans, Michael Kalab, Astrid Dempfle, Nicolai Maass et al.
Cancers 2025, 17(5), 780; https://doi.org/10.3390/cancers17050780
Available online: https://www.mdpi.com/2072-6694/17/5/780

15. “ARIH1 Inhibition Promotes Microtubule Stability and Sensitizes Breast Cancer Cells to Microtubule-Stabilizing Agents”
by Mohamed Elshaer, Breege V. Howley and Philip H. Howe
Cancers 2025, 17(5), 782; https://doi.org/10.3390/cancers17050782
Available online: https://www.mdpi.com/2072-6694/17/5/782

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office